Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study.
Brenner
B
B
Rambam Medical Center, Haifa, Israel. b_brenner@rambam.health.gov.il
Hoffman
R
R
Carp
H
H
Dulitsky
M
M
Younis
J
J
D000026:Abortion, Habitual / Q000188:drug therapy / Q000517:prevention & control*; D004305:Dose-Response Relationship, Drug; D004342:Drug Hypersensitivity; D017984:Enoxaparin / Q000008:administration & dosage* / Q000633:toxicity; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use / Q000633:toxicity; D006801:Humans; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000188:drug therapy; D011256:Pregnancy Outcome; D019851:Thrombophilia / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome
D017984:Enoxaparin; D006495:Heparin, Low-Molecular-Weight